ArticleMicrobiologyOpen2026
Water Soluble-Nitrogenous Secondary Metabolites From Talaromyces annesophieae MD2 Exhibit Anti-Bacterial, Anti-Cancer, Anti-Oxidant, and Cytoprotective Activities.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study focused on biological activities and chemical characterization of secondary metabolites from the fungus Talaromyces annesophieae MD2 (GenBank: PQ252671). The dichloromethane extract (DCM-E) of its culture supernatant was fractionated using chromatographic techniques. Initially, three main fractions were first prepared from DCM-E. Subsequently, the selected active fraction 2 was subfractionated into six subfractions. The subfraction 3 demonstrated high water solubility and strong antibacterial activity against both gram-positive and gram-negative bacteria (MIC values of 105.41, 82.76, 71.92, and 70.38 µg/mL against B. cereus, S. aureus, E. coli, and K. pneumoniae, respectively). It exhibited selective anticancer activity through regulation of autophagy- and apoptosis-related pathways without affecting healthy cells (IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.